Helen Toledano – Research output — Tel Aviv University

View Scopus Profile

Research activity per year

65 Article
2 Comment/debate
2 Letter
1 Chapter

2 results

Filter

2024
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial, (Nature Medicine, (2023), 10.1038/s41591-023-02668-y)
Kilburn, L. B., Khuong-Quang, D. A., Hansford, J. R., Landi, D., van der Lugt, J., Leary, S. E. S., Driever, P. H., Bailey, S., Perreault, S., McCowage, G., Waanders, A. J., Ziegler, D. S., Witt, O., Baxter, P. A., Kang, H. J., Hassall, T. E., Han, J. W., Hargrave, D., Franson, A. T. & Yalon Oren, M. & 22 others, Toledano, H., Larouche, V., Kline, C., Abdelbaki, M. S., Jabado, N., Gottardo, N. G., Gerber, N. U., Whipple, N. S., Segal, D., Chi, S. N., Oren, L., Tan, E. E. K., Mueller, S., Cornelio, I., McLeod, L., Zhao, X., Walter, A., Da Costa, D., Manley, P., Blackman, S. C., Packer, R. J. & Nysom, K., May 2024, In: Nature Medicine. 30, 5, p. 1500 1 p.
Research output: Contribution to journal › Comment/debate

Open Access
2022
Correction to: COVID‑19 infection in pediatric patients treated for cancer (International Journal of Clinical Oncology, (2022), 27, 2, (448-454), 10.1007/s10147-021-02068-7)
Oz-Alcalay, L., Elitzur, S., Amitai, N., Toledano, H., Barzilai-Birenboim, S., Avrahami, G., Gilad, G., Vardi, Y., Dvori, M., Izraeli, S., Livni, G. & Gilad, O., Feb 2022, In: International Journal of Clinical Oncology. 27, 2, p. 455 1 p.
Research output: Contribution to journal › Comment/debate

Open Access